Compare DMRA & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DMRA | CNOB |
|---|---|---|
| Founded | 2011 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2020 | 1995 |
| Metric | DMRA | CNOB |
|---|---|---|
| Price | $31.80 | $32.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $43.00 | $31.25 |
| AVG Volume (30 Days) | 372.2K | ★ 422.2K |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 121.48 | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $42.85 |
| Revenue Next Year | N/A | $7.27 |
| P/E Ratio | ★ N/A | $21.71 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.50 | $23.20 |
| 52 Week High | $34.89 | $34.14 |
| Indicator | DMRA | CNOB |
|---|---|---|
| Relative Strength Index (RSI) | 60.76 | 48.60 |
| Support Level | $22.71 | $32.48 |
| Resistance Level | $31.77 | $34.04 |
| Average True Range (ATR) | 1.63 | 0.49 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 87.75 | 17.86 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets, and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental, and consumer wages.